ClearSky, dedicated to providing clear diagnosis for the neurodegenerative diseases

LID-Monitor is researched and developed by ClearSky Medical Diagnostics Limited, a spinout company from the University of York in the UK, founded by a group of computer science academics, clinicians and pharma industry veterans from all over the world.

Meet the team

ClearSky is specialised in developing digital technologies for the diagnosis and monitoring of Parkinson’s, Alzheimer’s and a range of other neurodegenerative
conditions. ClearSky tackles complex medical problems like Parkinson’s and dementia with a fresh approach by applying years of research of artificial intelligence in medical applications.

The core technology behind ClearSky’s devices is based on unique biologically-inspired computer algorithms developed in close collaboration with leading medical centres and specialists worldwide.

Our work is clinically led and clinically validated. ClearSky has developed a portfolio of non-invasive devices that provide a safe, quick and objective assessment of patients’ symptoms over the past ten years.